Teleflex Launches the LMA® Gastro™ Airway for Airway Management During Endoscopic Procedures
January 10 2017 - 6:30AM
Business Wire
Global airway management provider launches innovative technology
to address airway management challenges associated with endoscopic
procedures.
The LMA® Gastro™ Airway is the first laryngeal mask designed
specifically to facilitate esophageal access and promote airway
control during endoscopic procedures.
Teleflex Incorporated (NYSE:TFX), a leading global provider of
medical technologies for critical care and surgery, has today
announced the launch of the new LMA® Gastro™ Airway with Cuff
Pilot™ Technology – the first laryngeal mask specifically designed
to facilitate esophageal access and promote airway control during
endoscopic procedures.
The use of moderate-to-deep sedation during endoscopy is a
common practice around the world. Respiratory depression from
sedative drugs and airway obstruction requiring intervention are
known risks associated with endoscopic procedures, with studies
demonstrating that hypoxemia can occur in 11-50% of cases.1-3 In
the United States there are more than 6.9 million upper endoscopies
performed each year.4 Today, many of these are undertaken without
an airway management device in place.
The LMA® Gastro™ Airway is the latest innovation by Teleflex
under the LMA® Brand. Indicated for airway management in adult
patients undergoing endoscopic procedures, the LMA® Gastro™ Airway
is designed to maintain a patent airway throughout the procedure to
support patient safety.
The LMA® Gastro™ Airway also features Cuff Pilot™ Technology –
an integrated, cuff pressure indicator that constantly monitors
cuff pressure, detecting changes resulting from fluctuations in
temperature, nitrous oxide levels and movements within the airway.
It provides at-a-glance feedback, highlighting changes that could
affect patient safety.5 The continuous control of intracuff
pressure through in-line (or integrated) cuff pressure monitoring
has been clinically shown to reduce the risk of post-operative
airway morbidity or leaks.5,6 In addition, the LMA® Gastro™ Airway
has an integral bite block to reduce the potential for damage to
the endoscope due to biting, helping to avoid costly repairs.
"Teleflex has a rich history of innovation focused on solving
unmet clinical needs and this latest innovation under the LMA®
Brand is testament to that," said Justin McMurray, President of the
Teleflex Anesthesia & Emergency Medicine Division. "Our LMA®
Brand revolutionized airway management with the development of the
original laryngeal mask airway. We are excited to continue this
tradition with the introduction of the LMA® Gastro™ Airway to
empower clinicians to achieve airway control during endoscopic
procedures."
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people's lives. We apply
purpose-driven innovation - a relentless pursuit of identifying
unmet clinical needs - to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® - trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Cuff Pilot, LMA, LMA Gastro are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other countries.
© 2017 Teleflex Incorporated. All rights reserved. MC-002891
References
- Cote GA, Hovis RM, Ansstas MA, et al.
Incidence of sedation-related complications with propofol use
during advanced endoscopic procedures. Clin Gastroenterol Hepatol.
2010;8(2):137-142.
- Qadeer MA, Rocio Lopez A, Dumot JA,
Vargo JJ. Risk factors for hypoxemia during ambulatory
gastrointestinal endoscopy in ASA I-II patients. Dig Dis Sci.
2009;54(5):1035-1040.
- de Paulo GA, Martins FP, Macedo EP,
Goncalves ME, Mourao CA, Ferrari AP. Sedation in gastrointestinal
endoscopy: a prospective study comparing
nonanesthesiologist-administered propofol and monitored anesthesia
care. Endosc Int Open. 2015;3(1):E7-E13.
- Peery AF, Dellon ES, Lund J, et al.
Burden of gastrointestinal disease in the United States: 2012
update. Gastroenterology. 2012;143(5):1179-1187 e1171-1173.
- Martin DP, Bhalla T, Thung A, Tobias
JD. Clinical evaluation of a novel LMA with a color-coded pressure
gauge. Int J Pediatr Otorhinolaryngol. 2013;77(1):76-78.
- Wong DT, Tam AD, Mehta V, Raveendran R,
Riad W, Chung FF. New supraglottic airway with built-in pressure
indicator decreases postoperative pharyngolaryngeal symptoms: a
randomized controlled trial. Can J Anaesth.
2013;60(12):1197-1203.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170110005048/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024